XPO, Inc.
XPO, Inc. is one of the largest providers of asset-based less-than-truckload (LTL) transportation in North America.
Following the spinoff of the contract logistics division (GXO) in 2021 as well as its freight brokerage operations (RXO) in 2022, XPO Logistics (NYSE: XPO) is moving closer to be the pure play asset-based less-than-truckload carrier.
As per our previous report on XPO as on October 26, 2022, a ‘Buy’ recommendation was given on the stock at $48.370, and noted below are the details of support and resistance provided in our previous report:
Recommendation Summary as on October 26, 2022 (prior to the spin-off)
Key Updates
XPO has announced that it has wrapped up the previously announced spin-off of RXO, Inc., which led to the creation of 2 independent as well as publicly traded companies. Now, RXO would begin “regular way” trading on NYSE under the symbol “RXO.”
This separation was completed via a distribution to XPO stockholders of 1 share of RXO common stock for every 1 share of XPO common stock held as of the record date for the distribution (October 20, 2022). RXO shares were distributed at 12:01 a.m. (ET) on November 1, 2022. The distribution was intended to be tax-free to XPO stockholders. The opening stock price of RXO was $20.25 per share on November 1, 2022.
XPO’s Daily Chart
Source: REFINITIV; Analysis: Kalkine Group
Considering the current trading levels as well as risks associated, it is prudent to liquidate the stock at the current levels.
Hence, a ‘Sell’ rating has been provided on the stock at the closing price of $43.94 as of 2nd February 2023.
RXO, Inc.
RXO, Inc. provides transportation solutions. It specializes in freight forwarding, truckload, and supply chain management, as well as offers data science, technology operations, and machine learning solutions.
As per our previous report on RXO as on 23 December 2022, a ‘Speculative Buy’ recommendation was given on the stock at $16.02, and noted below are the details of support and resistance provided in our previous report:
Recommendation Summary as on 23 December 2022 (post the spin-off)
Source: REFINITIV; Analysis: Kalkine Group
Considering the current trading levels as well as risks associated, it is prudent to liquidate the stock at the current levels.
Since RXO Inc (NYSE: RXO) is trading separately, a ‘Sell’ rating has been provided on that stock as well at the closing price of $20.09 as of 2 February 2023.
Note: This report may be updated with details around fundamental and technical analysis, price/ chart in due course, as appropriate.
Note 1: Past performance is neither an indicator nor a guarantee of future performance.
Note 2: The reference date for all price data, currency and technical indicators is February 2, 2023. The reference data in this report has been partly sourced from REFINITIV.
Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.
Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.
Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.
There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.
You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.
The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.
Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.
Please also read our Terms & Conditions and Financial Services Guide for further information.
Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this report or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.
Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.